EBS — Emergent BioSolutions Inc. Common Stock
8 mentions in the last 24 hours · 0.04% of all mentions
Why people talked about EBS (2026-11-03)
- Emergent BioSolutions reported Q3 2026 Non-GAAP EPS of -$0.36, beating estimates by $0.03.
- The company's Q3 revenue was $110 million, missing estimates by $13.2 million.
- The stock closed at $6.81 on Friday, trading above the 50-day SMA but below the 200-day SMA.
| RSS Bundle | 3 | news |
| Bluesky | 2 | community |
| GDELT | 1 | news |
| Marketaux | 1 | news |
| SEC EDGAR 8-K | 1 | filings |